Studying of analgesic and anti-inflammatory activity of 2,4-dioxobutanoic acid hydrazine derivatives

Abstract

Objective. To study the analgesic and anti-inflammatory activity of water-soluble hydrazine derivatives of 2,4-dioxobutanoic acids, as well as to determine the relationship between the structure of substances and their biological effects.

Materials and methods. The laboratory synthesis methods were applied to obtain 2-hydrazine derivatives of 2,4-dioxobutanoic acids. The compounds were tested for biological activity using a hot plate test in mice and an acute inflammatory reaction caused by carrageenan-induced paw edema in rats.

Results. The analgesic activity of four compounds is comparable to that of nimesulide. One of the substances obtained is found to exhibit higher anti-inflammatory activity than nimesulide during the 1st and 3rd hours of the experiment. Two compounds with a combination of high analgesic and anti-inflammatory activity were identified. The effect of certain radicals in the structure of the substances on the activities studied was discovered.

Conclusions. The revealed relationship between the structure of original compounds and their biological activities can be used in the further synthesis and search for new domestic pharmaceutical substances with investigated effects.

Keywords

2 / 4-dioxobutanoic acids / analgesic activity / anti-inflammatory activity

References

[1] Pulina N.A., Kuznetsov A.S., Rubtsov A.E. Chemistry of iminofurans: ix. Synthesis and cyclization of (2z)-2-{(2z)-2-[2-(3-R-adamantan-1-yl)-2-oxoethylidene]hydrazinyl}-4-(het) aryl-4-oxobut-2-enoic acids. Russian. Journal of Organic Chemistry 2015; 51 (7): 967–971 (in Russian).

[2] Пулина Н.А., Кузнецов А.С., Рубцов А.Е. Химия иминофуранов IX. Синтез и циклизация (2Z)-2-{(2Z)-2-[2-(3-R-адамантан-1-ил)-2-оксо-этилиденгидразинил}-4-(гет)арил-4-оксобут-2-еновых кислот. Журнал органической химии 2015; 51 (7): 986–990.

[3] Kozhukhar V.Yu., Kuznetsov A.S., Pulina N.A., Makhmudov R.R., Rubtsov A.E. Study of the analgesic activity of new compounds containing fragments of morpholine, piperazine and adamantane. Sovremennye problemy nauki i obrazovaniya 2015; 3, available at: http://www. science-education.ru/ru/article/view?id=17523 (in Russian).

[4] Кожухарь В.Ю., Кузнецов А.С., Пулина Н.А., Махмудов Р.Р., Рубцов А.Е. Исследование анальгетической активности новых соединений, содержащих фрагменты морфолина, пиперазина и адамантана. Современные проблемы науки и образования 2015; 3, available at: http://www. science-education.ru/ru/article/view?id=17523.

[5] Kuznetsov A.S., Sobin F.V., Kozhuk- har V.Yu., Pulina N.A. Evaluation of research prospects of biologically active substances in the series of 4-R-2-hydroxy-4-oxo-2-butenoic acid derivatives. Global scientific potential 2013; 4: 8–11 (in Russian).

[6] Кузнецов А.С., Собин Ф.В., Кожу- харь В.Ю., Пулина Н.А. Оценка перспективности поиска биологически активных соединений в ряду производных 4-R-2-гидрокси-4-оксо-2-бутеновых кислот. Глобальный научный потенциал 2013; 4: 8–11.

[7] Kuznetsov A.S., Dubrovina S.S., Pulina N.A. Antimicrobial activity of new 4-(het)aryl-4-oxobut-2-enoic acids derivatives. Pharmacy 2018; 4: 40–43 (in Russian).

[8] Кузнецов А.С., Дубровина С.С., Пули- на Н.А. Противомикробная активность новых производных 4-(гет)арил-4-оксобут-2-еновых кислот. Фармация 2018; 4: 40–43.

[9] Pulina N.A., Kozhukhar V.Yu., Kuznetsov A.S., Starkova A.V., Rubtsov A.E. Synthesis and search for compounds with hemostatic activity in the series of 4-(het)aryl-4-oxobut-2-enoic acid derivatives. Russian Chemical Bulletin 2017; 8: 1497–1502 (in Russian).

[10] Пулина Н.А., Кожухарь В.Ю., Кузнецов А.С., Рубцов А.Е., Старкова А.В. Синтез и поиск соединений с гемостатической активностью в ряду производных 4-(гет)арил-4-оксобут-2-еновых кислот. Известия Академии наук. Серия химическая 2017; 8: 1497–502.

[11] State Pharmacopoeia of the Russian Federation of the Ministry of Health of the Russian Federation. 14th ed. М. 2018; 1: 1814 (in Russian).

[12] Государственная фармакопея Российской Федерации Министерства здравоохранения Российской Федерации. XIV изд. М. 2018; 1: 1814.

[13] Guidelines for conducting preclinical studies of drugs. Part One. Pod red. A.N. Mironova. Moscow: Grif i K 2013; 944 (in Russian).

[14] Руководство по проведению доклинических исследований лекарственных средств. Часть первая. Под ред. А.Н. Миронова. М.: Гриф и К 2013; 944.

[15] Order of the Ministry of Health of the Russian Federation of April 1, 2016 no. 199n. Registered with the Ministry of Justice of the Russian Federation on August 15, 2016 Registration no. 43232 Moscow 2016 (in Russian).

[16] Приказ Министерства здравоохранения Российской Федерации от 1 апреля 2016 г. № 199н. Зарегистрировано в Министерстве юстиции Российской Федерации 15 августа 2016 г. Регистрационный № 43232. М. 2016.

RIGHTS & PERMISSIONS

Pulina N.A., Kuznecov A.S., Chashchina S.V.